Company intelligence / Profile preview

Inorevia

Paris, Île-de-France, Franceinorevia.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Inorevia has developed and commercialized highly efficient walk-away instruments that automate and miniaturize biological protocols using patented microfluidic technologies. Their solutions enable high-quality multi-omics data from limited or challenging samples by maximizing molecule preservation and reducing background noise. The company is focused on accelerating life sciences research through advanced sample prep automation.

Modalities: DeviceMicrofluidics-based technologySample preparation technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Inorevia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inorevia.

Explore the full profile